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MRI Detection of Secondary Damage After Stroke
Chronic Iron Accumulation in the Thalamus of the Rat Brain
Carles Justicia, PhD; Pedro Ramos-Cabrer, PhD; Mathias Hoehn, PhD
Background and Purpose—Iron plays a central role in many metabolic processes. Under certain pathological situations
it accumulates, producing negative effects such as increasing damage by oxidative stress. The present study examined
long-term iron accumulation in a stroke model with secondary degeneration, using MRI and histological techniques.
Methods—Male Wistar rats (n22) were subjected to 60 minutes MCA occlusion. MR images (T2- and T2*-weighted)
were obtained weekly between weeks 1 and 7 after reperfusion, and at weeks 10, 14, 20, and 24. Histological iron
detection and immunohistochemical examination for different markers (NeuN, GFAP, OX-42, HO-1, and APP) were
performed at the 3 survival time points (3, 7, and 24 weeks).
Results—Infarcts affecting MCA territory were evident on T2-weighted imaging, and all animals showed deficits on
behavioral tests. In the thalamus, T2 hyperintensity was detected 3 weeks after stroke, and disappeared around week 7
when T2*-weighted images showed a marked hypointensity in that area. Histology revealed neuronal loss in the
thalamus, accompanied by strong microglial reactivity and microglial HO-1 expression. APP deposits were detected in
the thalamus from week 3 on and persisted until week 24. Iron storage was detected in microglia at week 3, in the
parenchyma at week 7, and around APP deposits at week 24.
Conclusions—T2*-weighted MRI allows the detection of secondary damage in the thalamus after MCAO. Iron
accumulation in the thalamus is mediated by HO-1 expression in reactive microglia. (Stroke. 2008;39:1541-1547.)
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Reduction of regional cerebral blood flow may result inbrain infarction. The most common experimental brain
infarction model is the occlusion of the middle cerebral artery
(MCAO), directly affecting ipsilateral cerebral cortex and
caudate putamen. Focal brain ischemia also leads to changes
in regions remote from the primary affected areas.1,2 These
changes include vasogenic edema3,4 and excitotoxicity,5–7
which can contribute to secondary damage early after the
insult. Cerebral infarct is one of the most common causes of
Wallerian anterograde degeneration. After proximal axonal or
somal injury, a degeneration of axons and myelin sheaths is
observed. This axonal degeneration and myelin clearance
give rise to accumulation of proteins and ions in the distal
affected regions,8 contributing to the secondary lesion. Sec-
ondary damage also generates chronic microglial responses in
the thalamus.9,10
Iron is essential for cell function and is involved in many
important processes such as oxygen transport, storage, and
activation. Iron storage is mediated by ferritin. High plasma
ferritin levels have been related to poorer prognosis after
stroke11 because ferritin is a source of free iron. Accumula-
tion of iron, after hypoxia/ischemia in newborns, can be
detected with MRI techniques.12 This iron accumulation
causes pronounced susceptibility effects, thus reducing local
T2 relaxation time, which results in hypointensity on T2*-
weighted (T2*-W) images. High iron content of blood cells
allows the detection of different events such as hemorrhages
in the brain parenchyma and hemorrhagic transformation
after brain infarct. Other pathologies, such as Alzheimer
disease, can lead to iron accumulation in the brain. Different
metal ions (iron, copper, zinc) have been found to accumulate
around senile plaques.13
Heme-containing proteins are a source of iron during brain
injury. Inducible heme oxygenase (HO-1) is a heat shock
protein that responds to stress, catabolizing free heme into
iron, carbon monoxide, and biliverdin (an antioxidant). Thus,
HO-1 has been suggested to be protective against oxidative
stress.14
The aim of this work was to study, by MRI techniques, the
different events taking place during and after thalamic sec-
ondary degeneration. Our hypothesis was that HO-1, tran-
siently expressed by reactive microglia in the thalamus,
contributes to chronic iron accumulation in the thalamus and
is detectable by MRI.
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Materials and Methods
Animals
Male Wistar rats (n22; 280 to 320 g body weight at the beginning
of the study; Harlan; Borschen, Germany) were used for the
longitudinal study of secondary degeneration after stroke. One
animal with abnormal T2* MRI before stroke induction was ex-
cluded from the study. Rats were euthanized at 3 different survival
time points: 3 weeks (n5), 7 weeks (n8), and 24 weeks (n8).
All experiments were performed in accordance with the National
Institute of Health animal protection guidelines and approved by the
local governmental authorities.
Induction of Ischemia
Focal cerebral ischemia was produced by 1-hour intraluminal occlu-
sion of MCA followed by reperfusion. Rats were kept under 1 to
1.5% halothane in nitrous oxide/oxygen (70:30) during all surgical
procedures. The right common carotid artery was exposed, and
branches of the external carotid artery (ECA) were electrocoagulated
and sectioned. The pterygopalatine artery was tied close to the
internal carotid artery. The common carotid artery was permanently
occluded with a silk thread (3/0). A filament (4/0 Ethicon sutures),
coated with silicon, was introduced through the ECA to the level of
the MCA branching point. During MCAO rats showed a decrease in
cortical blood flow measured by LDF with normal blood flow
recovery after reperfusion. All animals showed infarction in the right
parietal cortex and caudate-putamen (MCA territory) on T2-
weighted MRI at 48 hours after stroke induction. Other brain
regions, irrigated by anterior and posterior cerebral arteries, were
not affected.
Adhesive Removal Test
Somatosensory deficits were assessed with the adhesive removal
test. Experiments were done during the dark part of the day/night
cycle, when animals show higher activity. The adhesive removal test
was performed as described by Schallert and colleagues15 and
applied in our laboratory.16 Briefly, 2 adhesive paper dots (12 mm
diameter) were accurately attached to the distal-radial region on the
wrist of each forelimb. Both the time to contact each paw and the
time to remove paper dots were recorded 3 times, with a minimal
interval of 5 minutes between consecutive trials. Before the first
(preischemic) MRI session animals were trained for 3 consecutive
days. Tests were always carried out the day before each MRI
experiment.
MRI
MRI experiments were conducted on 4.7 T and 7 T horizontal bore
magnets (Bruker BioSpin, Germany) with 20-cm wide actively
shielded gradient coils (100 and 200 mT/m, respectively). Radiofre-
quency transmission was achieved with home-built Helmholtz coils
(12 cm diameter); signal was detected using 2.2 cm surface coils,
positioned over the head of the animal, which was fixed with tooth
bar, ear plugs, and adhesive tape. Transmission and reception rf coils
were actively decoupled from each other. Gradient-echo pilot scans
were performed at the beginning of each imaging session for
accurate positioning of the animal inside the magnet bore. T2-
weighted (T2-W) images were acquired using a multi-slice multi-
echo spin-echo sequence with the following acquisition parameters:
field-of-view3.23.2 cm2, image matrix128128 (isotropic in-
plane resolution of 250 m), 16 consecutive slices of 1 mm
thickness, repetition time TR3 seconds, 16 echoes with echo time
TE of 7.5 ms (7T) or 12 ms (4.7T). T2*-weighted 3D data sets were
acquired only at 4.7 T (to take advantage of the shorter T1 values at
lower field) using gradient-echo sequence with the following acqui-
sition parameters: field-of-view2.02.01.0 cm3, image ma-
trix16016040 (zero-filled to 25625664, spatial resolution:
7878156 m), TR/TE200/20 ms, excitation pulse angle30°.
All images were processed using ImageJ (Rasband, W.S., ImageJ,
NIH, http://rsb.info.nih.gov/ij).
Immunohistochemistry
Brains of all animals were processed for histological procedures.
Expression of HO-1 and APP (Amyloid Precursor Protein) and
identification of neurons, astrocytes, and microglia was performed
by immunohistochemistry. Rats were perfused with 0.1 mol/L
sodium phosphate buffer (PBS) pH 7.2, followed by 4% paraformal-
dehyde in the same buffer. Brains were postfixed overnight with the
same fixative at 4°C and cryoprotected in 30% sucrose solution for
3 days. 40-m-thick coronal sections were cut with a freezing
microtome (Leica, Nussloch, Germany) and stored in a cryopro-
tectant solution. Free-floating sections were used for immunohisto-
chemical detection for neurons, glial cells, inducible heme-oxygen-
ase, and amyloid precursor protein.
Endogenous peroxidases were blocked with methanol-H2O2 and
unspecific-binding sites with 3% normal horse serum for 2 hours at
room temperature. Sections were incubated at 4°C with a mouse
monoclonal antibody against either NeuN (neuronal marker; Chemi-
con Int, diluted 1:400), GFAP (astrocyte marker; Advanced Immu-
Figure 1. A, Experimental design indicating 3 animal groups
with different survival times: 3 weeks, 7 weeks, and 24 weeks
after MCAO. At every indicated time point behavioral tests and
MRI were performed followed by histology/immunohistochemis-
try at the end of the survival period. B, Sticky tape removal test.
Time to contact and time to remove the adhesive dots showed
no differences between left and right forepaw before MCAO
(W0). Delays in time to contact and to remove the tape indicate
the corticostriatal damage caused by MCAO. Animals showed a
slight tendency to improve long time after stroke.
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nochemicals Inc, diluted 1:400), OX42 (microglial marker; Stress-
gen, diluted 1:500), HO-1 (Chemicon Int, diluted 1:500), and APP
(Chemicon Int, diluted 1:400). This was followed by biotinylated
goat antimouse antibody (Vectastain, Vector) diluted 1:200 for 1
hour at room temperature and the avidin-biotin complex (ABC kit,
Vector Laboratories; 1:100) for 1 hour. The reaction was developed
with 0.05% diaminobenzidine and 0.03% H2O2.
Double immunohistochemistry was carried out after the first
immunoreaction with OX42 or APP. The second primary antibodies
were: a mouse monoclonal antibody against HO-1 (diluted 1:500)
and a mouse monoclonal antibody against OX42 (diluted 1:500).
Sections previously reacted with the first primary antibody were
incubated with the second primary antibody, followed by a corre-
sponding biotinylated secondary antibody. All sections were then
incubated with the avidin-biotin complex, washed with 0.01 mol/L
sodium phosphate buffer (pH 6), and preincubated for 10 minutes
with 0.01% benzidine dihydrochloride and 0.025% sodium nitrofer-
ricyanide in 0.01 mol/L sodium phosphate buffer (pH 6). The
reaction was developed with this solution containing 0.005% H2O2.
All sections were mounted, dehydrated, and coverslipped with
mounting medium (Enthelan, Fluka).
Images were acquired using Leica MZ FL III and Leica DM RB
light microscopes, both equipped with a CCD camera.
Pearl Prussian Blue Staining
Coronal sections (40 m) from all animals were processed for iron
detection. Sections were mounted on glass slides. Hydrochloric acid
(2%) and potassium hexacyanoferrat (2%) were mixed just before
use (working solution). Sections were rinsed in working solution for
20 minutes. After washing in distilled water sections were either
counterstained with nuclear fast red or processed for OX42
immunostaining.
Image Analysis
Infarct volume was determined from quantitative T2 maps recorded
at 3 weeks after stroke. Lesion volume was defined as an increase of
T2 by more than 2 standard deviations above the homotopic
contralateral values.
Statistical Analysis
The statistical comparison of lesion volumes at 3 weeks after
stroke and of response times of the behavioral test was performed
for all studied animals at weeks 3, 7, and 24 using Student t test. A
probability value of 0.05 was considered significant.
Results
Figure 1A shows the experimental design. Behavioral tests
indicated significant differences between healthy and im-
paired hemispheres. Time-to-contact and time-to-remove
(Figure 1B) the sticky tape increased dramatically on the left
forepaw (contralateral to the lesion), whereas the right fore-
paw did not express significant changes.
Figure 2. Successive changes of T2- and
T2*-weighted MR images in the same rat after
60-minute MCAO. T2-W images (second echo,
TE15 ms) showed a transient hyperintensity,
suggestive of edema in the right ipsilateral
thalamus 3 weeks after ischemia (arrow in A),
whereas this hyperintensity had disappeared at
7 weeks (B, C). 3D T2*-weighted images were
acquired at the same MR sessions, showing a
persistent hypointensity (arrowheads in E and
F) in the thalamus from week 7 until the end of
the experiment (24 weeks).
Figure 3. Chronological changes in thalamic expression of different cell population markers and inducible heme-oxigenase-1 after
1-hour MCAO. Four different markers (in columns) were tested at different time points after ischemia. Right thalamic nuclei correspond-
ing to VPL and VPM showed neuronal loss detected as lack of NeuN immunostain at 3, 7 and 24 weeks (A, E, I). Glial reactivity and
proliferation was tested with antibodies against GFAP (astrocytes: B, F, J) and OX42 (microglia: C, G, K). Marked GFAP expression was
evident 7 weeks after ischemia (F). Twenty-four weeks after stroke, astrocytes were localized around the affected area, suggesting the
formation of a glial scar (J). Strong microglial reactivity, detected by OX42 expression, was evident from the 3rd week and increased
with time, probably attributable to cell proliferation (C, G, K). Heme-oxigenase-1 expression (D, H, L), detected in the thalamus 3 weeks
after ischemia (D) disappeared with time (H, L), indicating a transient expression of this stress protein. Scale bar2 mm.
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Hyperintensities of T2-W images showed similar infarct
extents as well as locations affected. For calculation of infarct
volumes quantitative T2 maps were constructed from the
multi-echo train for every time point studied from pre-MCAO
to 6 months after occlusion. Statistical analysis of infarct
volumes, based on T2 maps, was performed at 3 weeks when
vasogenic edema as a confounding factor was already dis-
solved again. Infarct volumes did not show significant dif-
ferences between groups (15561, 13446, 17853 mm3
for 3-, 7-, and 24-weeks group, respectively). T2 signal of
infarcted areas was homogeneously high in caudate-putamen
and parietal cortex from the third week after infarct to the last
observation time point, indicating cystic transformation of the
infarct core. Thalamic T2-W signal changes started the third
week after stroke, showing a hyperintensity in thalamic nuclei
ipsilateral to the lesion (Figure 2A). Contralateral thalamic
nuclei did not show changes on T2-W signal intensity.
Affected thalamic regions were identified as ventropostero-
medial (VPM) and ventroposterolateral (VPL) nuclei by
comparison with the Paxinos and Watson atlas.17 Thalamic
hyperintensity was not detected from 7 to 24 weeks after
MCAO (Figure 2B and 2C). At the same experimental
sessions 3D T2*-weighted sequences were acquired. Evolu-
tion of primary infarct showed irregular hypointensities in the
infarct core according to T2*-W imaging, indicating microb-
leedings, reactive microglia, or infiltrating macrophages.
The same MR modalities showed patterns of evolution in
the thalamus different from those in primarily affected
cortical and striatal regions. Thalamic T2*-W images were
apparently normal 3 weeks after the infarct (Figure 2D),
whereas an intense hypointensity became evident 7 weeks
after stroke (Figure 2E), persisting up to 24 weeks (Figure
2F). These regions with signal intensity decrease coincided
with regions showing T2-W hyperintensity at 3 weeks after
the ischemic insult (VPL and VPM).
Three weeks after ischemia neuronal loss was evident in
VPL and VPM thalamic nuclei and remained until the end of
the experiment (24 weeks; Figure 3A, 3E, and 3I). Glial
reactivity was detectable from the third week on (Figure 3B
and 3C). Astrocytic reaction was localized mainly around the
VPL and VPM at 7 and 24 weeks after the infarct, forming an
astrocytic scar (Figure 3F and 3J). Microglial reaction dra-
matically increased at 7 weeks (Figure 3G) compared to the
expression at 3 weeks (Figure 3C). Microglial OX42 expres-
sion was still very important 24 weeks after stroke (Figure
3K). HO-1 expression in the ipsilateral thalamus was in-
creased 3 weeks after MCAO compared to later time points,
when only a small number of cells were detectable and these
only barely (Figure 3D, 3H, and 3L). Cells expressing HO-1
at 3 weeks were identified by coexpression of microglial
markers (Figure 4C).
Reactive microglia in the thalamus showed iron content at
this time point (Figure 4B). Iron accumulation in the thalamus
was evident from the third week after the onset of ischemia
(Figure 4A). Iron was first clearly localized intracellularly
(Figure 5A), whereas 7 weeks after infarct the iron showed a
parenchymal distribution (Figure 5B). After 6 months iron
was localized around thalamic structures similar to Alzheimer
plaques (Figure 5C).
APP expression was localized as small dots in the VPL and
VPM 3 weeks after ischemia. An increase in APP deposition
was visually evident from week 7 after ischemia and was
present until the end of the experiment (Figure 6A, 6B, and
6C). Double staining showed high density of microglial cells
around the APP deposits (Figure 6D, 6E, and 6F).
Discussion
We have shown that high-resolution MRI is ideally suited to
study long-term changes in brain regions remote from the
primary infarct. We demonstrate here for the first time that
T2*W-MRI permits to detect dynamics of iron accumulation
Figure 4. Thalamic ipsilateral detection of microglia (OX42),
heme-oxigenase-1 (HO-1), and iron at 3 weeks after MCAO.
Pearl Prussian blue iron detection with nuclear fast red counter-
staining shows intracellular storage of iron in the thalamus (A).
Iron was stored mainly in microglial cells at this time point,
detected by double staining iron(blue)/OX42(brown) (B). HO-1
(black) was expressed by microglial (brown) cells in the thala-
mus 3 weeks after stroke (C). Scale bar50 m.
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in the thalamus, long after the onset of the ischemic episode.
We have provided possible mechanisms that explain changes
detected by MRI in the thalamus, including inflammation,
oxidative stress, and microglial reactivity, among others.
One-hour occlusion of the MCA causes infarct formation
in its supplying territory affecting ipsilateral basal ganglia
and parietal cortex. These regions were affected in all animals
in this study. But brain infarct is a dynamic process that
includes anterograde and retrograde fiber degeneration of the
axon, finally affecting parts remote from the primary infarct.1
Neuronal secondary damage is a phenomenon that follows a
long time course. MRI changes in remote areas have been
reported in models of permanent MCA occlusion, indicating
early alterations in thalamic nuclei and substantia nigra.18,19
Using a model of transient MCA occlusion we were able to
detect dynamic MRI changes in different brain regions, such
as VPL and VPM thalamic nuclei, internal capsule, substantia
nigra, and medial geniculate complex, among others. Tha-
lamic neuronal death is detectable from 4 to 7 days after
cortical lesion in mice and rats5,20 and is delayed, appearing
from 1 to 7 months after cortical lesion, in rabbits.21 In a
transient MCAO model in rats neuronal death in the thalamus
was not detectable before 7 days, whereas a primary astro-
cytic and microglial reaction appeared already 3 days after
the insult.22 In our model we detected extensive neuronal
death and glial reactivity, both events causing localized
edema in the VPL and VPM nuclei 3 weeks after the ischemic
insult. Increase in extracellular water content is detectable by
increase in T2 values. Later permanent decrease in T2*
values indicates a chronic accumulation of iron in the same
thalamic nuclei.
Fetal cortical transplants reduce thalamic atrophy attribut-
able to retrograde degeneration in thalamic nuclei ipsilateral
to cortical lesions. This suggests that some trophic support is
needed for the survival of thalamic neurons.23 Altered levels
of trophic factors causes degeneration of neurons and oligo-
dendrocytes, both highly sensitive to such changes, inducing
myelin degeneration.24 This neuronal and oligodendrocytic
degeneration leads to changes of connected regions, remote
from the primary infarct, such as the thalamus and induces a
delayed microglial reactivity and heme oxygenase expres-
sion.25 Inducible heme-oxygenase (HO-1 or HSP-32) is a
chaperone, hardly expressed under normal conditions but
highly induced under oxidative stress,26 degrading heme
groups and generating biliverdin (a powerful antioxidant),
CO, and iron.14 We found transient expression of HO-1 at 3
weeks, at the same time that inflammation, delayed neuronal
Figure 5. Iron accumulation in ipsilateral thalamic nuclei. Iron
accumulates with a changing pattern. Three weeks after ische-
mia intracellular localization of iron is predominant (A), whereas
7 weeks after stroke iron is mainly distributed in the paren-
chyma (B). 24 weeks after ischemia iron tended to be distrib-
uted around plaque-like formations (C). Scale bar200 m.
Figure 6. Amyloid precursor protein
expression and localization. APP was
accumulated first at synaptic terminals,
appearing as small dots, 3 weeks after
ischemia (A). Seven weeks after the infarct
APP tended to aggregate (B) and form
senile plaque-like aggregates (C) 24
weeks after stroke. At the same time
points APP(brown)/OX42(blue) double
staining showed microglial proliferation
and reactivity around the APP aggregates
(D, E, F). Scale bar200 m in A, B, C;
100 m in D, E, F.
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death, and microglial reaction took place. HO-1 expression
has been used as an index of oxidative stress in neurodegen-
erative diseases such as Alzheimer disease27 or amyotrophic
lateral sclerosis,28 suggesting that HO-1 could be an indicator
of chronic oxidative stress. Different mechanisms try to
neutralize damage caused by oxidative stress. The brain is
particularly vulnerable to oxidative stress because of its high
metabolic rate, using 20% of basal oxygen consumption.
Inflammatory processes generate oxygen free radicals. The
increase in HO-1 might contribute to an increased suscepti-
bility to oxidative stress in elderly people.29,30 Long-term
expression of HO-1 is associated with Wallerian degenera-
tion. HO-1 induction could also provide an index of micro-
glial and macrophage stress response to injury.26
Mononuclear phagocyte lineage cells express ferritin.
Light-chain ferritin, localized mainly in microglia in rats, is
implicated in long-term iron storage.26,31,32 HO-1 is found in
both glial cells and neurons, whereas ferritin is only ex-
pressed by glia. Microglial cells have the capacity to seques-
ter free iron, limiting iron mediated cell injury. Iron is
potentially toxic, catalyzing hydroxyl radical formation via
the Fenton reaction.33
Brain iron promotes protein oligomerization resulting in
highly prevalent age-related proteinopathies such as Alzhei-
mer disease (AD), Parkinson disease (PD), and Dementia
with Leavy Bodies (DLB).34,35 Protein accumulation is a
widely observed phenomenon in neurodegenerative diseases.
APP is an integral membrane protein expressed in many
tissues and concentrated in the synapses of neurons. Amyloid
beta (A) is generated by APP proteolysis and is one of the
primary components of amyloid plaques. APP production is
present under normal conditions and at all ages but is
increased under stress situation. APP is a marker of axonal
degeneration, accumulates because of the disruption of ax-
onal transport,36 and is highly expressed by astrocytes in the
ischemic border.37 APP and A chronic deposition have been
reported in the thalamus after MCAO in rats38 and humans.39
There exists a balance between A production and elimina-
tion acting through different mechanisms (microglial cells,
astrocytes, insulin-degrading enzyme, among others). Tha-
lamic APP accumulation could be the consequence of an
increased production, or a decrease in elimination, or a
combination of both mechanisms. We have found chronic
APP expression, mainly by microglial cells from the third
week after stroke on, in the thalamus ipsilateral to the infarct,
in agreement with other reports.38 APP accumulation shows a
time-dependent varying pattern. At the earliest time point
studied here APP was localized mainly as small dots, prob-
ably attributable to axonal degeneration. After 7 weeks APP
adopted a plaque-like morphology with iron accumulation
around the plaques. Alzheimer disease is linked to inflamma-
tion, with microglial and astrocytic increased reactivity, and
metal biology, with presence of ions such as copper, zinc,
and iron.13,30 These metals accelerate A peptide aggrega-
tion and enhance metal-catalyzed oxidative stress associated
with amyloid plaque formation. The presence of an iron-
responsive element (IRE) in the 5UTR of the APP (APP
5UTR) provided the first molecular biological support for
the present model that APP of AD is a metalloprotein.40
Neural toxicity is significantly attenuated after pretreatment
of A with iron-chelators, suggesting that the toxicity of A
is mediated via redox-active iron that enhances cellular
oxidative stress.41 Thus, iron can contribute to APP and A
toxicity and accumulation associated to stroke.
Summary
In the present investigation, we describe, for the first time,
long-term changes detected by MRI in thalamic nuclei after
MCAO in rats. These changes include neuronal loss and glial
reactivity accompanied by edema, and followed by iron
deposition, providing a mechanism that helps explain the
observed temporal profile of T2*-weighted contrast on MRI.
Acknowledgments
Help with the immunohistochemical staining from Christiane
Sprenger is gratefully acknowledged.
Sources of Funding
The investigation was supported by grants from the EU-FP6 pro-
gram: DiMI (LSHB-CT-2005-512146), EMIL (LSHC-CT-2004-




1. Fujie W, Kirino T, Tomukai N, Iwasawa T, Tamura A. Progressive
shrinkage of the thalamus following middle cerebral artery occlusion in
rats. Stroke. 1990;21:1485–1488.
2. Iizuka H, Sakatani K, Young W. Neuronal damage in the rat thalamus
after cortical infarcts. Stroke. 1990;21:790–794.
3. Nordborg C, Johansson BB. Secondary thalamic lesions after ligation of
the middle cerebral artery: an ultrastructural study. Acta Neuropathol
(Berl). 1996;91:61–66.
4. Garcia JH, Liu KF, Ye ZR, Gutierrez JA. Incomplete infarct and delayed
neuronal death after transient middle cerebral artery occlusion in rats.
Stroke. 1997;28:2303–2309.
5. Ross DT, Ebner FF. Thalamic retrograde degeneration following cortical
injury: An excitotoxic process? Neuroscience. 1990;35:525–550.
6. Domercq M, Etxebarria E, Perez-Sanmartin A, Matute C. Excitotoxic
oligodendrocyte death and axonal damage induced by glutamate trans-
porter inhibition. Glia. 2005;52:36–46.
7. Johnston MV. Excitotoxicity in perinatal brain injury. Brain Pathol.
2005;15:234–240.
8. Pesini P, Copp J, Wong H, Walsh JH, Grant G, Ho¨kfelt T. An immuno-
histochemical marker for Wallerian degeneration of fibers in the central
and peripheral nervous system. Brain Res. 1999;828:41–59.
9. Myers R, Manjil LG, Franckoviak RS, Cremer JE. [3H]PK11195 and the
localisation of secondary thalamic lesion following focal ischemia in the
rat motor cortex. Neurosci Lett. 1991;133:20–24.
10. Pappata S, Levasseur M, Gunn R, Myers R, Crouzel C, Syrota A, Jones
T, Kreutzberg G, Banati RB. Thalamic microglial activation in ischemic
stroke detected in vivo by PET and [11C]PK11195. Neurology. 2000;55:
1052–1054.
11. Carbonell T, Rama R. Iron, oxidative stress and early neurological dete-
rioration in ischemic stroke. Curr Med Chem. 2007;14:857–874.
12. Khong PL, Zhou LJ, Ooi GC, Chung BH, Cheung RT, Wong CN. The
evaluation of Walleriann degeneration in chronic paediatric middle
cerebral artery infarction using diffusion tensor MR imaging. Cere-
brovasc Dis. 2004;18:240 –247.
13. Maynard CJ, Bush AI, Masters CL, Cappai R, Qiao-Xin L. Metals and
amyloid-beta in Alzheimer’s disease. Int J Exper Pathol. 2005;86:
147–159.
14. Koistinaho J, Miettinen S, Keina¨nen R, Vartiainen N, Roivainen R,
Laitinen JT. Long-term induction of haem oxygenase-1 (HSP-32) in
astrocytes and microglia following transient focal brain ischaemia in the
rat. Eur J Neurosci. 1996;8:2265–2272.
1546 Stroke May 2008
 by on February 10, 2011 stroke.ahajournals.orgDownloaded from 
15. Schallert T, Whishaw IQ. Bilateral cutaneous stimulation of the somato-
sensory system in hemidecorticate rats. Behav Neurosci. 1984;98:
518–540.
16. Wegener S, Weber R, Ramos-Cabrer P, Uhlenku¨ken U, Wiedermann D,
Kandal K, Villringer A, Hoehn M. Subcortical lesions after transient
thread occlusion in the rat: T2-weighted magnetic resonance imaging
findings without corresponding sensorimotor deficits. J Magn Reson
Imaging. 2005;21:340–346.
17. Paxinos G, Wattson C. The Rat Brain in Stereotaxic Coordinates. IV ed.
Academic Press, San Diego. 1998;
18. Nakane M, Tamuar A, Nagaoka T, Hirakawa K. MR detection of sec-
ondary changes remote from ischemia: preliminary observations after
occlusion of the middle cerebral artery in rats. Am J Neuroradiol. 1997;
18:945–950.
19. Abe O, Nakane M, Aoki S, Hayashi N, Masumoto T, Kunimatsu A, Mori
H, Tamura A, Ohmoto K. MR imaging of postischemic neuronal death in
the substantia nigra and thalamus following middle cerebral artery
occlusion in rats. NMR Biomed. 2003;16:152–159.
20. Sorensen JC, Dalmau I, Zimmer J, Finsen B. Microglial reactions to
retrograde degeneration of tracer-identified thalamic neurons after frontal
sensorimotor cortex lesions in adult rats. Exper Brain Res. 1996;112:
203–212.
21. Matthews MA. Death of the central neuron: an electron microscopic
study of thalamic retrograde degeneration following cortical ablation.
J Neurocytol. 1973;2:262–288.
22. Hermann DM, Mies G, Hata R. Microglial and astrocytic reactions prior
to onset of thalamic cell death after traumatic lesion of the rat senso-
rimotor cortex. Acta Neuropathologica (Berlin). 2000;99:147–153.
23. Sharp FR, Gonzalez MF. Fetal cortical transplants ameliorate thalamic
atrophy ipsilateral to neonatal frontal cortex lesions. Neurosci Lett. 1986;
71:247–251.
24. Drojdahl N, Fenegr C, Nielsen HH, Owens T, Finsen B. Dynamics of
oligodendrocyte responses to anterograde axonal (Wallerian)and terminal
degeneration in normal and TNF-transgenic mice. J Neurosci Res. 2004;
75:203–217.
25. Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, Zilles K. Heme
oxygenase-1(HSP-32) induction in neurons and glial cells of cerebral
regions and its relation to iron accumulation after focal cortical photo-
thrombosis. Exper Neurol. 2001;168:1–22.
26. Mautes AE, Bergeron. M, Sharp FR, Panter SS, Weinzierl M, Guenther
K, Noble LJ. Sustained induction of heme oxygenase-1 in the traumatized
spinal cord. Exper Neurol. 2000;166:254–265.
27. Schipper HM, Bennet DA, Liberman A, Bienias JL, Schneider JA, Kelly
J, Arvanitakis Z. Glial heme oxygenase-1 expression in Alzheimer’s
disease and mild cognitive impairment. Neurobiol Aging. 2006;27:
252–261.
28. Dwyer BE, Lu SY, Nishimura RN. Heme oxygenase in the experimental
ALS mouse. Exper Neurol. 1998;150:206–212.
29. Hirose W, Ikematsu K, Tsuda R. Age-associated increases in heme
oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Legal
Med (Tokyo). 2003;5:s360–s366.
30. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain
aging and neurodegenerative disorders. Nat Rev. 2004;5:863–873.
31. Connor JR, Boeshore KL, Benkovic SA, Menzies SL. Isoforms of ferritin
have a specific cellular distribution in the brain. J Neurosci Res. 1994;
37:461–465.
32. Melhase J, Gieche J, Widmer R, Grune T. Ferritin levels in microglia
depend upon activation: Modulation by reactive oxygen species. Biochem
Biophys Acta. 2006;1763:854–859.
33. Crichton RR, Wilmert S, Legssyer R, Ward RJ. Molecular and cellular
mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg
Biochem. 2002;91:9–18.
34. Bush AI. The metallobiology of Alzheimer’s disease. Trends Neurosci.
2003;26:207–214.
35. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M,
Huang D, Edwards N, Mintz J. Brain ferritin iron may influence age- and
gender-related risks of neurodegeneration. Neurobiol Aging. 2007;28:
414–423.
36. Smith DH, Uryu K, Saatman KE, Trojanowski JQ, McIntosh TK. Protein
accumulation in traumatic brain injury. Neuromol Med. 2003;4:59–72.
37. Popa-Wagner A, Schroder E, Walker LC, Kessler C. beta-amyloid pre-
cursor protein and ss-amyloid peptide immunoreactivity in the rat brain
after middle cerebral artery occlusion: effect of age. Stroke. 1998;29:
2196–2202.
38. Van Groen T, Puurunen K, Ma¨ki HM, Sivenius J, Jolkkonen J. Trans-
formation of diffuse (beta)-amyloid precursor protein and (beta)-amyloid
deposits to plaques in the thalamus after transient occlusion of the middle
cerebral artery in rats. Stroke. 2005;36:1551–1556.
39. Aho L, Jolkkonen J, Alafuzoff I. beta-amyloid aggregation in human
brains with cerebrovascular lesions. Stroke. 2006;37:2940–2945.
40. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter
L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush
AI, Giordano T, Gullans SR. An iron-responsive element type II in the
5-untranslated region of the Alzheimer’s amyloid precursor protein tran-
script. J Biol Chem. 2002;277:45518–45528.
41. Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion
M, Perry G, Smith MA. Redox-active iron mediates amyloid-b toxicity.
Free Rad Biol Med. 2001;30:447–450.
Justicia et al MRI of Secondary Thalamic Damage 1547
 by on February 10, 2011 stroke.ahajournals.orgDownloaded from 
